511509-BOM

Vivo Bio Tech Ltd.

BSE: 511509

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Biotechnology

19.03+0.0 (+0.16%)

8 Sep, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

42.23

P/E (TTM)

P/B

0.45

P/S (TTM)

0.77

EV/EBITDA

5.30

CAPE (5Y)

11.68

ROE (TTM)

-2.00

ROCE (TTM)

6.99

ROA (TTM)

-1.06

Avg 3Y ROE

4.59

Earnings 3Y CAGR

-42.19

Sales 3Y CAGR

1.59

Sales 5Y CAGR

-0.19

Debt/Equity

0.72

Consensus TP

Strong Buy %

Promoter Holding

30.62

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Vivo Bio Tech Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Moderate revenue growth and above median growth of industry

The company delivered moderate revenue growth of 12.34% for 12-month ended 30 Jun 2026 and the growth was 14.48 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: -2.14

Value 12.34

-72.3212.34

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.72 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.03 in the last 1 year

What is Debt to Equity?

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -6.77% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low and declining ROE

The company reported low ROE of -2.0% for 12-month ended 30 Jun 2026 and ROE declined by -1301 bps from 1 year ago

What is ROE (FY)?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -126.05% for 12-month ended 30 Jun 2026 and the growth was 86.48 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

High operating margin but declining trend

The company reported strong operating margin of 16.14% for 12-month ended 30 Jun 2026 but operating margin declined by -873 bps from 1 year ago

What is Operating profit margin?

Financial Snapshot

See detailed analysis

Multi-year trends for Vivo Bio Tech Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Vivo Bio Tech Ltd. Shareholding Pattern

Quarterly breakdown of Vivo Bio Tech Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	34.70	34.70	34.70	34.70	36.58	39.84	39.84	39.84	39.67	42.16	42.16	42.16	42.08	42.08	42.08	42.08	42.08	42.08	42.08	38.88	40.85	36.43	35.16	35.16	35.43	30.62
Indian Promoter	34.70	34.70	34.70	34.70	36.58	39.84	39.84	39.84	39.67	42.16	42.16	42.16	42.08	42.08	42.08	42.08	42.08	42.08	42.08	38.88	40.85	36.43	35.16	35.16	35.43	30.62
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	65.30	65.30	65.30	65.30	63.42	60.16	60.16	60.16	60.33	57.84	57.84	57.84	57.92	57.92	57.92	57.92	57.92	57.92	57.92	61.12	59.15	63.57	64.84	64.84	64.57	69.38
Bodies Corporate	2.14	2.09	2.07	2.08	1.98	1.84	1.59	1.50	19.84	17.79	17.62	17.61	17.71	17.95	18.58	18.51	17.02	16.32	15.77	11.71	11.53	22.19	24.89	24.29	24.37	29.06
Others (incl. Retail) No. of shareholders	63.16 6,815	63.21 6,853	63.23 7,087	63.22 7,430	61.44 8,009	58.32 8,946	58.57 10,229	58.66 11,326	40.49 12,413	40.05 12,591	40.22 12,995	40.23 13,007	40.21 13,021	39.97 12,943	39.34 12,960	39.41 15,569	40.90 18,926	41.60 18,807	42.15 19,499	49.41 21,121	47.62 21,879	41.38 21,834	39.95 21,586	40.55 21,563	40.20 21,366	40.32 21,166

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Vivo Bio Tech Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
More Agrisupplies & Services Private Limited	08 Jun 2026	buy	₹ 24.28	6.99 lac	-
Shri Shri Resorts Pvt Ltd	08 Jun 2026	sell	₹ 24.23	10.00 lac	-
Vean Smart Infra Private Limited	08 Jun 2026	buy	₹ 24.12	2.94 lac	-
Mahesh Rathore	16 Sep 2025	sell	₹ 38.00	1.08 lac	₹ 41.04 lac

No corporate action data available.

Company Profile

Overview of Vivo Bio Tech Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Vivo Bio Tech Limited is an India-based company, which is a comprehensive preclinical clinical research organization (CRO) serving pharmaceutical and biotech firms. It operates in the biotechnology segment. It provides integrated discovery, development & regulatory services to pharmaceutical, agroch...

Key personnel

Mr. Bhavish Vijayvargiya

Compliance Officer, Company Secretary

Mr. Kompella Sri KalyanD

Chief Financial Officer, Additional Whole-time Director

Mr. Mangipudi Kalyan RamD

Whole Time Director

Mr. Tejomurthula Viswaswara Kaladhar KuppambhotlaD

Additional Non-Executive Director

Dr. Alangudi Sankaranarayanan, Ph.D.D

Non-Executive Director

Mr. Satyanarayana VedulaD

Non-Executive Non-Independent Director

Ms. Priya Rajender GodaD

Additional Non-Executive Independent Director

Mr. Mangipudi Kalyan RamD

Non-Executive Independent Director

View all

Incorporated on

12 Feb 1987

Last Annual

Last Interim

No. of Employees

IPO date

23 May 1994

Free Float

75,90,862

Website

http://www.vivobio.com/

Phone no.

+914048199999

Address

3 Floor, Ilyas Mohammed Khan Estate, # 8-2-672/ 5 & 6, Road No.1, Banjara Hills, HYDERABAD, 500034, India

Frequently Asked Questions

What is the current share price of Vivo Bio Tech Ltd.?

The current share price of Vivo Bio Tech Ltd. is ₹ 19.03 as of 8 Sep 2026.

What is the market capitalisation of Vivo Bio Tech Ltd.?

The market capitalisation of Vivo Bio Tech Ltd. stands at ₹ 42.23 Cr.

What is the PE ratio of Vivo Bio Tech Ltd.?

The Price-to-Earnings (PE) ratio of Vivo Bio Tech Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Vivo Bio Tech Ltd.?

Vivo Bio Tech Ltd. has a Return on Equity (ROE) of -2.00% and a Return on Capital Employed (ROCE) of 6.99% as per the latest financial reports.

What is the 52-week high and low of Vivo Bio Tech Ltd.?

The 52-week high of Vivo Bio Tech Ltd. is - and the 52-week low is -.

What is the dividend yield of Vivo Bio Tech Ltd.?

The dividend yield of Vivo Bio Tech Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Vivo Bio Tech Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 40.32% of Vivo Bio Tech Ltd. shares.

What sector does Vivo Bio Tech Ltd. belong to?

Vivo Bio Tech Ltd. operates in the Healthcare sector.

What is the beta of Vivo Bio Tech Ltd.?

The beta of Vivo Bio Tech Ltd. is 1.00, indicating its price volatility relative to the broader market. Over the past 1 year, Vivo Bio Tech Ltd. has delivered an absolute return of -48.66%.

What is the RSI of Vivo Bio Tech Ltd.?

The 14-day Relative Strength Index (RSI) of Vivo Bio Tech Ltd. is 37.96, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Vivo Bio Tech Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Vivo Bio Tech Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Company Profile

Stock Analysis